Dynavax Technologies Corp. (DELISTED) (DVAX:DL)
Dynavax Technologies Market Cap : 1.820B for Feb. 19, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Merck & Co., Inc. | 303.45B |
| Amicus Therapeutics, Inc. | 4.499B |
| Agios Pharmaceuticals, Inc. | 1.714B |
| Hyperion DeFi, Inc. | 26.89M |
| Edgewise Therapeutics, Inc. | 3.103B |
Market Cap Related Metrics
| PS Ratio | 6.480 |
| Price to Book Value | 3.408 |
| Price to Free Cash Flow | 26.59 |
| Price | 15.50 |
| Earnings Yield | -2.46% |
| Operating PE Ratio | 205.19 |
| Normalized PE Ratio | 197.96 |